S
KROS icon

SignatureFD’s Keros Therapeutics KROS Stock Holding History

SignatureFD’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Sell
1,280
-682
-35% -$10.5K ﹤0.01% 2362
2025
Q4 		$39.9K Buy
1,962
+311
+19% +$5.46K ﹤0.01% 1779
2025
Q3 		$26.1K Buy
1,651
+354
+27% +$5.23K ﹤0.01% 1981
2025
Q2 		$17.3K Buy
1,297
+300
+30% +$4.05K ﹤0.01% 2110
2025
Q1 		$10.2K Buy
997
+921
+1,212% +$10.7K ﹤0.01% 2350
2024
Q4 		$1.2K Hold
76
– – ﹤0.01% 2990
2024
Q3 		$4.41K Hold
76
– – ﹤0.01% 2611
2024
Q2 		$3.47K Hold
76
– – ﹤0.01% 2617
2024
Q1 		$5.03K Hold
76
– – ﹤0.01% 2537
2023
Q4 		$3.02K Buy
+76
New +$2.38K ﹤0.01% 2657
2023
Q2 		– Sell
-10
Closed -$427 – 3304
2023
Q1 		$427 Hold
10
– – ﹤0.01% 3118
2022
Q4 		$480 Hold
10
– – ﹤0.01% 3115
2022
Q3 		$0 Buy
+10
New +$347 ﹤0.01% 3232
2022
Q2 		– Sell
-13
Closed -$1K – 3239
2022
Q1 		$1K Buy
+13
New +$667 ﹤0.01% 3016
2021
Q3 		– Sell
-18
Closed -$1K – 3135
2021
Q2 		$1K Buy
+18
New +$975 ﹤0.01% 2754

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return